These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 9314555)

  • 1. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.
    Thiessen S; Serra P; Amrani A; Verdaguer J; Santamaria P
    Diabetes; 2002 Feb; 51(2):325-38. PubMed ID: 11812739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
    Lühder F; Katz J; Benoist C; Mathis D
    J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
    Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
    J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
    Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
    J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells.
    Pilström B; Böhme J
    Immunology; 1997 Apr; 90(4):483-8. PubMed ID: 9176099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
    Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
    J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
    Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
    Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
    La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
    J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetogenic MHC class II promotes the differentiation of MHC-promiscuous autoreactive T cells into FOXP3+ regulatory T cells.
    Tsai S; Serra P; Clemente-Casares X; Yamanouchi J; Thiessen S; Slattery RM; Elliott JF; Santamaria P
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3471-6. PubMed ID: 23401506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7.
    Wen L; Wong FS; Sherwin R; Mora C
    J Immunol; 2002 Apr; 168(7):3635-40. PubMed ID: 11907129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.